Changes to Nerve Cell Membrane May Promote Alpha-synuclein’s Toxic Turn
Changes in the composition of fat molecules on the membranes of nerve cells appear to change how the alpha-synuclein protein interacts…
Articles by Patricia Inácio, PhD
Blood Glucose Levels Appear to Affect Motor Skills and Their Decline
Abnormal blood sugar (glucose) levels, either lower or higher than the norm, appears to be linked with a faster progression…
Parkinson’s UK Invests Up to £800,000 in New Trial Testing GDNF
Parkinson’s UK is paving the way for a future clinical trial that will continue to test a naturally occurring…
Blackfynn Acquires Therapy Potentially Ready for Phase 3 Testing
Blackfynn announced that its is acquiring the rights to a candidate Parkinson’s disease treatment that others gave up on but…
Potential ASO Therapies for Patients With GBA Mutations Ready for Testing
Q-State Biosciences has developed a set of optimized antisense oligonucleotides (ASOs) that may serve as potential therapies for…
Animal Work Into Stem Cell Treatment for Parkinson’s Honored by Journal
A scientist at the University of Latvia claimed a journal’s Young Investigator Award for her research showing how small vesicles derived…
Vercise Genus, 4th-generation DBS Treatment, Coming Soon to US
Vercise Genus, a fourth-generation system for deep brain stimulation (DBS) to treat people with Parkinson’s disease, is now available…
Spiroco 4mg Prolonged-release XL Tablets Discontinued
Teva has discontinued Spiroco (ropinirole) 4mg XL prolonged-release tablets due to factors out of the company’s control, according…
Two Small Trials Evaluating Focused Ultrasound in Treating Parkinson’s
Two small clinical trials are assessing MRI-guided focused ultrasound as a nonsurgical alternative for targeting the striatum — a brain…
Holding to Mediterranean Diet Lowers Parkinson’s Risk for Women, Study Finds
Women who adhere closely to a Mediterranean diet in their 30s and 40s have a lower risk of Parkinson’s disease…